References

Brochier, B., I. Thomas, B. Bauduin, T. Leveau and P.P. Pastoret et al., 1990. Use of a vaccinia-rabies recombinant virus for the oral vaccination of foxes against rabies. Vaccine, 8: 101-104.
PubMed  |  

Cliquet, F. and J. Barrat, 2008. Efficacy and bait acceptance of vaccinia vectored rabies glycoprotein vaccine in captive foxes (Vulpes vulpes), raccoon dogs (Nyctereutes procyonoides) and dogs (Canis familiaris). Vaccine, 26: 4627-4638.

Cox, J.H. and B. Dietzschold, 1977. Rabies virus glycoprotein. II. Biological and serological characterization. Infect. Immunity, 16: 754-759.

De Wind, N., F. Wagenaar, J. Pol, T. Kimman and A. Berns, 1992. The pseudorabies virus homology of the herpes simplex virus UL21 gene product is a capsid protein which is involved in capsid maturation. J. Virol., 66: 7096-7103.
Direct Link  |  

Hong, Q., P. Qian, X.M. Li, X.L. Yu and H.C. Chen, 2007. A recombinant pseudorabies virus co-expressing capsid proteins precursor P1-2A of FMDV and VP2 protein of porcine parvovirus: A trivalent vaccine candidate. Biotechnol. Lett., 29: 1677-1683.
PubMed  |  

Hu, R.L., S. Zhang, A.R. Fooks, H. Yuan and Y. Liu et al., 2006. Prevention of rabies virus infection in dogs by a recombinant canine adenovirus type-2 encoding the rabies virus glycoprotein. Microb. Infect., 8: 1090-1097.
CrossRef  |  

Jestin, A., T. Foulon, B. Pertuiset, P. Blanchard and M. Labourdet, 1990. Rapid detection of pseudorabies virus genomic sequences in biological samples from infected pigs using polymerase chain reaction DNA amplification. Vet. Microbiol., 23: 317-328.
PubMed  |  

Kieny, M.P., R. Lathe, R. Drillien, D. Spehner and S. Skory et al., 1990. Expression of rabies virus glycoprotein from a recombinant vaccinia virus. Nature, 312: 163-166.
Direct Link  |  

Klupp, B.G., B. Lomniczi, N. Visser, W. Fuchs and T.C. Mettenleiter, 1995. Mutations affecting the UL21 gene contribute to avirulence of pseudorabies virus vaccine strain Bartha. Virol., 212: 466-473.
PubMed  |  

Klupp, B.G., C.J. Hengartner, T.C. Mettenleiter and L.W. Enquist, 2004. Complete, annotated sequence of the pseudorabies virus genome. J. Virol., 78: 424-440.
CrossRef  |  Direct Link  |  

Klupp, B.G., S. Bottcher, H. Granzow, M. Kopp and T.C. Mettenleiter, 2005. Complex formation between the UL16 and UL21 tegument proteins of pseudorabies virus. J. Virol., 79: 1510-1522.
CrossRef  |  Direct Link  |  

Liu, Q., S. Gao, L. Jiang, L. Shang and J. Men et al., 2008. A recombinant pseudorabies virus expressing TgSAG1 protects against challenge with the virulent Toxoplasma gondii RH strain and pseudorabies in BALB/c mice. Microb. Infect., 10: 1355-1362.
PubMed  |  

Michael, K., B.G. Klupp, A. Karger and T.C. Mettenleiter, 2007. Efficient incorporation of tegument proteins pUL46, pUL49, and pUS3 into pseudorabies virus particles depends on the presence of pUL21. J. Virol., 81: 1048-1051.
Direct Link  |  

Olsen, L.M., T.H. Ch'ng, J.P. Card and L.W. Enquist, 2006. Role of pseudorabies virus Us3 protein kinase during neuronal infection. J. Virol., 80: 6387-6398.
CrossRef  |  Direct Link  |  

Qian, P. and X.M. Li, 2004. An approach to a FMD vaccine based on genetic engineered attenuated pseudorabies virus: One experiment using VP1 gene alone generates an antibody responds on FMD and pseudorabies in swine. Vaccine, 22: 2129-2136.

Sui, X., J. Yin and X. Ren, 2010. Antiviral effect of diammonium glycyrrhizinate and lithium chloride on cell infection by pseudorabies herpesvirus. Antiviral Res., 85: 346-353.
CrossRef  |  PubMed  |  Direct Link  |  

WHO, 2005. WHO expert consultation on rabies. WHO Technical Report Series 931, First Report. http://www.who.int/rabies/trs931_%2006_05.pdf

Wagenaar, F., J.M. Pol, N. de Windb and T.G. Kimmanc, 2001. Deletion of the UL21 gene in Pseudorabies virus results in the formation of DNA-deprived capsids: An electron microscopy study. Vet. Res., 32: 47-54.
CrossRef  |  

Wunner, W.H. and J.K. Larson, 1988. The molecular biology of rabies viruses. Rev. Infect. Dis., 4: S771-7S84.

Yarosh, O.K., A.I. Wandeler, F.L. Graham, J.B. Campbell and L. Prevec, 1996. Human adenovirus type 5 vectors expressing rabies glycoprotein. Vaccine, 14: 1257-1264.
PubMed  |  

Yuan, Z., S. Zhang, Y. Liu, F. Zhang, A.R. Fooks, Q. Li and R. Hu, 2008. A recombinant pseudorabies virus expressing rabies virus glycoprotein: Safety and immunogenicity in dogs. Vaccine, 26: 1314-1321.
PubMed  |